Trial intelligence / Profile preview

Gaboxadol in Elderly Primary Insomnia

NCT00209846Phase 3Completed

Sponsor
Lundbeck
Start
Jun 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of gaboxadol in Insomnia, sponsored by Lundbeck. Started Jun 2004; status: completed.

02

Drugs

gaboxadol
03

Conditions

Insomnia

Beyond the preview

Go deeper on NCT00209846.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00209846.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call